Wealth Enhancement Advisory Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Buy
249,780
+70,056
+39% +$3.8M 0.02% 648
2026
Q1
$0 Buy
179,724
+44,239
+33% +$3.54M ﹤0.01% 3616
2025
Q4
$13.2M Buy
135,485
+18,533
+16% +$1.82M 0.02% 604
2025
Q3
$11.2M Buy
116,952
+1,202
+1% +$124K 0.02% 613
2025
Q2
$12.1M Buy
115,750
+10,741
+10% +$1.09M 0.02% 572
2025
Q1
$10.6M Buy
105,009
+24,856
+31% +$2.5M 0.02% 561
2024
Q4
$7.16M Sell
80,153
-78,385
-49% -$6.9M 0.01% 672
2024
Q3
$13.3M Buy
158,538
+87,470
+123% +$6.9M 0.03% 447
2024
Q2
$5.47M Buy
71,068
+5,044
+8% +$369K 0.01% 661
2024
Q1
$4.52M Buy
66,024
+6,485
+11% +$417K 0.01% 691
2023
Q4
$3.44M Sell
59,539
-1,929
-3% -$103K 0.01% 714
2023
Q3
$3.25M Buy
+61,468
New +$3.22M 0.01% 687
2023
Q2
Sell
-7,328
Closed -$367K 518
2023
Q1
$367K Buy
+7,328
New +$345K ﹤0.01% 419
2019
Q2
Sell
-27,867
Closed -$1M 206
2019
Q1
$1M Buy
+27,867
New +$1.06M 0.06% 141
2017
Q1
Sell
-96,166
Closed -$2.08M 140
2016
Q4
$2.08M Buy
+96,166
New +$2.1M 0.25% 52

Other funds holding BSX

Wealth Enhancement Advisory Services's BSX Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Boston Scientific (BSX) stake by 39% in Q2 2026, buying an estimated $3.8M and bringing the position to 249,780 shares worth $10.7M. The position accounts for 0.02% of the portfolio, ranked #648.

Wealth Enhancement Advisory Services first reported a position in BSX in Q4 2016 and has held it in 15 quarters since. The position peaked at $13.3M in Q3 2024. 303 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Wealth Enhancement Advisory Services held 249,780 shares of Boston Scientific worth $10.7M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 70,056 Boston Scientific shares in Q2 2026, an estimated $3.8M.
  • Boston Scientific made up 0.02% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #648 holding.
  • Wealth Enhancement Advisory Services first reported a position in Boston Scientific in Q4 2016 and has held it in 15 quarters since.
  • Wealth Enhancement Advisory Services's Boston Scientific position peaked at $13.3M in Q3 2024.
  • 303 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.